Prevnar 20 Generic Name & Formulations
Pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) 46.2micrograms of saccharides per 0.5mL; susp for IM inj; contains aluminum.
Prefilled syringes—1, 10
Prevnar 20 Indications
Active immunization against pneumonia and invasive disease caused by S. pneumoniae due to serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F.
Prevnar 20 Dosage and Administration
≥18yrs: 0.5mg IM once.
<18yrs: not established.
Prevnar 20 Contraindications
Allergies to any diphtheria toxoid-containing vaccine.
Prevnar 20 Boxed Warnings
Prevnar 20 Warnings/Precautions
Have epinephrine inj available. Immunocompromised. Pregnancy. Nursing mothers.
Prevnar 20 Pharmacokinetics
Prevnar 20 Interactions
Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response. Antibody responses may be diminished if Pneumovax 23 was received 1 to 5 years prior to Prevnar 20.
Prevnar 20 Adverse Reactions
Inj site reactions (eg, pain, swelling), muscle pain, fatigue, headache, arthralgia.
Prevnar 20 Clinical Trials
Prevnar 20 Note
Prevnar 20 Patient Counseling